跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59 条关于
“Chk1”
全部
59
临床试验
19
药物
25
机构
0
资讯
15
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
去年
Extrachromosomal DNA Fuels Cancer Evolution, Reveals New Therapeutic Targets
去年
Unlocking Cancer's Code: Scientists Target DNA Circles for Novel Therapies
去年
Targeting Rogue DNA Loops Shows Promise in Treating Aggressive Cancers
去年
Acrivon Therapeutics to Showcase AP3 Platform and Clinical Program Updates at Upcoming R&D Event
去年
Circle Pharma to Reveal Dual Mechanism of Novel Cyclin A/B RxL Inhibitors at AACR 2025
去年
Acrivon Therapeutics Grants Equity Awards to Employees Under Nasdaq Rule 5635(c)(4)
去年
Boundless Bio Prioritizes BBI-355 and New ecDTx Program, Discontinues BBI-825 Development
4个月前
XtalPi-Enabled PRMT5 Inhibitor PEP08 Reaches Phase I Enrollment Milestone in Solid Tumor Trial
去年
Florida Cancer Specialists Expands Treatment Options Through Clinical Research
第 1 页,共 2 页
上一页
下一页